Billions of dollars are at stake, not just for the mRNA vaccine makers, but for efforts to develop new antiviral drugs, ones that can be patented and sold at a significant markup.
By Benjamin Braddock, AM GREATNESS
The April COVID surge in India is an interesting microcosm of what went wrong in this pandemic—and what went right.
As cases and deaths began to mount exponentially, a new wave of terrifying headlines and images also began to ripple across the West, accompanied by footage reminiscent of those first videos out of Wuhan and Iran in the early days of the pandemic.
A BBC report from outside of a hospital in Delhi was nothing short of gut-wrenching. Sick people on stretchers outside of the hospital, drawing their last labored breaths before a doctor or nurse could even see them. Frantic and traumatized family members begging for someone to come see their mother, their father, their sister, their brother. No one was coming. The people outside on the stretchers slipped quietly away into eternity.
That’s how it is with this virus. In most cases, it’s like a head cold or a bad case of the flu. But in some cases, if not properly treated, what seems like a banal infection rapidly spirals into a nightmare. Given the infectivity of the virus, it can spread faster than we can respond to it. And for India, this became the case at a national level. For much of the pandemic, COVID was so mild there relative to other countries that scientists were trying to figure out why they were doing so well.
Then came the April elections, which in India are carried out in phases rather than all in one go. There were huge rallies with politicians where hundreds of thousands of people gathered, a near perfect storm for the highly infectious Delta variant. India soon became the new global hotspot for COVID. The media maelstrom fed fears that a new wave would soon arrive in the West.
But seemingly overnight, stories about India’s COVID surge disappeared from Western media. Why?
I think it was because India was too good of a case study in how the virus can be defeated without experimental gene therapy vaccines. All it takes is a cheap, safe, widely used drug called Ivermectin.
In the late 1960s, a Japanese microbiologist, Satoshi ?mura, took a soil sample from a golf course near Tokyo, and the rest is, as they say, history. From this soil sample a new strain of bacteria was cultured, S. avermictilis, which was shown to have a remarkable effect on worms and other parasites. It quickly became a top-selling veterinary drug. In 1987, it was approved for human usage to treat the devastating tropical disease onchocerciasis (river blindness), a disease caused by worms and transmitted by flies which results in blindness if left untreated. Since then, more than 3.7 billion doses have been distributed globally, thanks in no small part to the tireless work of former President Jimmy Carter.
Over time its usage has expanded to treating other parasitic ailments, including head lice and scabies. Its safety profile is remarkable. It is so safe that it can be handed out to illiterate people in remote communities in the developing world with little instruction aside from “swallow this pill.”
In 2015, ?mura and his partner William Campbell were awarded the Nobel Prize in Medicine for their discovery of Ivermectin and its anti-parasitic properties. In 2012, Dr. Kylie Wagstaff discovered that Ivermectin also possessed antiviral properties. Early in the pandemic, Wagstaff and a team of researchers at Monash University in Melbourne, Australia conducted cell culture experiments to see if Ivermectin might be a useful therapy in the war on COVID. Their findings blew away all expectations.
Ivermectin halted the replication of the virus and completely eradicated it from the cell culture in under 48 hours. Their findings were released on April 3, 2020. Since then the findings have been replicated in over 60 trials and natural experiments, including 31 randomized control trials. Most of the suffering could have been avoided, but the bureaucrats who run our public health establishments condemned hundreds of thousands of Americans to death.
India’s surge was over in a matter of weeks. India’s doctors and public health authorities responded much more effectively and intelligently than our own. India’s Ministry of Health and Family Welfare revised its guidelines on April 28 to include a recommendation that asymptomatic and mild cases be treated with Ivermectin. Along with the government, the Indian Council of Medical Research and AIIMS, Delhi (India’s premier medical college and hospital), and many state government and health authorities also bucked World Health Organization recommendations and urged the use of Ivermectin. Since then, case counts have declined in Delhi by 99 percent, in Uttar Pradesh by 98 percent, in Uttarakhand by 97 percent, and in Goa by 90 percent.
Why would this information be suppressed by our media outlets? Well, under the FDA’s rules, an emergency use authorization (EUA) like the ones given for the three main experimental gene therapy vaccines can only remain in force so long as there is not a superior alternative therapy available. When you consider that the absolute risk reduction from taking Ivermectin as a COVID prophylaxis is far superior to that of the products from Pfizer, Moderna, and Johnson & Johnson, the justification for administering these experimental treatments disappears.
Billions of dollars are at stake, not just for the mRNA injections, but for efforts to develop new antiviral drugs, ones that can be patented and sold at a significant markup. Who would want to risk a heart attack when you could take a safe and effective pill once a week? Follow the money.
Fully Vaccinated Israelis May Be Forced To Quarantine After Exposure To “Delta” Variant
As concerns about the threat posed by the “Delta” variant, a mutant strain of COVID-19 first discovered in India that’s believed to be much more dangerous than rival strains, intensify, Israeli health officials have just been given the authority to quarantine pretty much anybody who is exposed to “Delta”, even if the individual is already fully vaccinated, Reuters reports.
The heavy-handed decision comes after a warning by new Israeli Prime Minister Naftali Bennett on Tuesday over new outbreaks caused by “Delta” . Bennett complained that daily infections have been rising again in Israel after weeks of a low plateau credited to the country’s record mass-vaccination drive.
Under the updated Health Ministry directive, vaccinated or formerly infected people can be ordered to self-isolate for up to 14 days if authorities suspect they may have passed in “close contact with a carrier of a dangerous virus variant.”
This could include having been passengers on the same plane, the ministry said, a possible dampener on Israel’s gradual opening of its borders to vaccinated summer tourists.
Addressing the Knesset (Israel’s parliament), Health Minister Nitzan Horowitz said fines of “thousands of shekels” might be levied against Israeli citizens or residents who travel to countries blacklisted as high COVID-19 risks.
On June 16, the Health Ministry listed Argentina, Brazil, South Africa, India, Mexico and Russia as off-limits to Israeli citizens or residents unless they receive special permission.
Some 55% of Israel’s 9.3MM population have received both doses of the Pfizer-BioNTech vaccine, and a steep drop in cases had prompted most economic restrictions to be lifted. But just days earlier, Israel announced plans to start vaccinating teenagers between the ages of 12 and 15.
Offering an example of how different countries are handling the potential threat posed by the “Delta” variant, analysts at Rabobank pointed out that the UK has a far larger presence of the Delta variant, but that hasn’t stopped it from allowing everyone to travel internationally from August; and Thailand, where COVID variants are also spreading, is opening up to tourism starting July 1 (in Phuket) and nationally beginning in October.
Meanwhile, Israel, which became the first developed nation in the world to vaccinate its population using mostly Pfizer doses, has already reinstated its mask rules after briefly removing them last week.
ZEROHEDGE DIRECTLY TO YOUR INBOX
Receive a daily recap featuring a curated list of must-read stories.
(2 of 2)
It sounds like a lot, but on a per capita basis India was one the nations in the world with the lower death rates associated with Covid, despite the early expectation to the contrary. But in March the new cases went from ~140 cases a day to triple that in a single month and continued to rise.
By early April, India’s national medical advisory group, the Directorate General of Health Services ordered guidance that Ivermectin be included in the prescribed care being issued to the public. By the end of April, the active cases had continued to skyrocket to nearly four million cases.
The deaths increased, but again, nothing by comparison to what was seen in either New York or New Jersey alone – still to this day, India has 1/10 of the deaths per million people as compared to either of those states and less than 1/2 the deaths compared to Israel in deaths per million people. At the beginning of May, India had determined to hand out kits with the prophylactic/early treatment kits at all homes in the affected territories.
This had a profound effect. State representatives went do to door and explained what to do and how to do it as the kits were directly handed to the public at their homes. The rate of cases dropped as precipitously as it had risen. Active cases in India fell incredibly to 1/6 of the peak number over the course of a single month. This can be seen plainly if you look at the charts on the Worldometer website.
No one anticipated this. To this day the cases continue to drop, as do the deaths. But the point of this article and in general regarding the shocking results in Indianshould not be related to the number of cases or deaths or even the disinformation from the WHO, which is still scandalous.
The shocking benefit is related to the striking rate at which the active cases and the new cases dropped – it is completely and dramatically different from the response seen in other countries. Usually, when the cases shoot up as in the US, or UK or Italy or Spain or Israel…. once the peak is met, the cases linger dropping slowly, usually very slowly back down. So the dramatic drop in cases is not incidental and is very exciting regarding the possible use of prophylaxis and early treatment protocols. These real-life field trials of the use of early treatment and prophylaxis supports the beneficial findings discovered in repeated trials over the past year.
/2
(1 of 2)
India’s experience with the Covid19 disease has been fascinating to observe, and as events unfold they become more and more revealing as to the use of treatment protocols that have exclusively gone unconsidered in countries with more advanced hospitalized/medical systems.
The treatment of their citizens was very important to the Modhi gov’t and they began by administering prophylaxis treatment to the first responders and later expanded that program to the entire population. India is an enormous nation in territory, but even more so by population size, having 1.4 billion citizens.
Following the outbreak of the Covid19 disease, there was a great concern of less industrialized nations where health and hygiene were considered less adaptable to combat a serious pandemic. India was considered to possibly be among those countries with this concern in mind.
As the US, England, Italy and other hallmark societies which held elite status medical systems went into a state of paralysis with their response to Covid, India was found to have less of a struggle with their response.
Then, however, with the vaccine rollout, India began to struggle to be able to bring about the vaccination of a sizeable part of their population. Still to this date, only ~16% of their public are vaccinated. So when the nation found their cases begin to rise, it was a great concern, and that concern was shared by the world as a whole.
The Indian gov’t reached out to many parties for advice and assistance. In April, Ivermectin was added to the preventative/early treatment by India’s which issues guidelines for treatment of the medical treatment plans. Over the year previous to this point, India was able to stabilize their Covid19 disease presence in the nation with a very slowly rising wave of cases that peaked last October with about one million cases.
/1
Interesting the writer is grouping the Johnson & Johnson vaccine together with the two mRNA vaccines. This is really shows a basic lack of knowledge of the products and makes completely question the writer’s basic competence on the subject matter.
Really the Covid problem is over in India. Does this writer also try and sell snow to Alaskans. Like good snake oil salesmen everywhere he does mix some truth with his inaccurate or exaggerated statements. So tired of this subject and so many people find crap
It’s cheap, it’s safe and it’s effective.
Two states in India were initially selected to compare the use of Ivermectin. Each state was comprably having cases spin out of control, increasing in weeks by 100-200%. One state, Delhi, pursued the Ivermectin trial and reduced its cases by 97% in three weeks. In another state, Tamil, cases increased 300% during the same period of time.
Following this the WHO declared that the use of Ivermectin might not be safe and stated that a 2-yr study should be pursued before any further use of the drug be allowed. Initially, the WHO was served with a Cease and Desist legal notice and more recently, they have been threatened with being sued for each death if their “disinformation campaign” was not halted.
So yes, the answer to the question of “Why would this information be suppressed by our media outlets?” is pretty clear. It’s cheap, it’s safe and it’s effective.
https://www.thedesertreview.com/opinion/columnists/indian-bar-association-sues-who-scientist-over-ivermectin/article_f90599f8-c7be-11eb-a8dc-0b3cbb3b4dfa.html
https://off-guardian.org/2021/06/09/whos-chief-scientist-served-with-legal-notice-for-disinformation-and-suppression-of-evidence/
Additional sources are readily available from even the simplest of internet searches. India should be a role model for the world. Unfortunately, the world was following the Guidance of the WHO, FDA and others rather than the fact.
It’s cheap, it’s safe and it’s effective.
Two states in India were initially selected to compare the use of Ivermectin. Each state was comprably having cases spin out of control, increasing in weeks by 100-200%. One state, Delhi, pursued the Ivermectin trial and reduced its cases by 97% in three weeks. In another state, Tamil, cases increased 300% during the same period of time.
Following this the WHO declared that the use of Ivermectin might not be safe and stated that a 2-yr study should be pursued before any further use of the drug be allowed. Initially, the WHO was served with a Cease and Desist legal notice and more recently, they have been threatened with being sued for each death if their “disinformation campaign” was not halted.
So yes, the answer to the question of
https://www.thedesertreview.com/opinion/columnists/indian-bar-association-sues-who-scientist-over-ivermectin/article_f90599f8-c7be-11eb-a8dc-0b3cbb3b4dfa.html
https://off-guardian.org/2021/06/09/whos-chief-scientist-served-with-legal-notice-for-disinformation-and-suppression-of-evidence/
Additional sources are readily available from even the simplest of internet searches. India should be a role model for the world. Unfortunately, the world was following the Guidance of the WHO, FDA and others rather than the fact.